What are driving factors of Intragastric Balloon Market ? Top players - Allurion Technologies, Districlass Medical, Apollo Endosurgery, Lexel, Helioscopie Medical Implants, Medsil, Obalon Therapeutics, ReShape Medical, Silimed and Spatz

Intragastric Balloon Market size is set to exceed USD 85 million by 2025; according to a new research report by Global Market Insights. Low prices of intragastric balloons as compared to other surgical procedures will spur demand for intragastric balloon in upcoming years. Price range of intragastric balloons is very low compared to other surgical procedures such as gastric bypass and adjustable gastric banding. Low prices will lead to increasing adoption rate of intragastric balloon, thereby driving business growth during the forecast period.

High demand for minimally invasive surgical procedures will significantly drive intragastric balloon market growth during the forecast period. Reduction in post-operative trauma and complications with use of non-surgical intragastric balloons is the major growth driver. Reduced hospital stays, and no blood loss are other advantages associated with use of advanced intragastric balloon across the forecast timeframe.

Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/1173

Single intragastric balloons market share was over 78% in 2018 with a growth rate of 12.4%. High growth rate is attributed to growing awareness among obese patients along with increasing acceptance of non-invasive and non-surgical procedures. Ease of administration and soft silicone material offers reduction of weight in short amount of time, that will stimulate business growth.

Saline filled balloon market accounted for largest revenue of USD 17.7 million in 2018. Easy detection of deflation due to methylene blue and improved ability to reduce weight will stimulate business growth. Improved design to provide maximum efficacy with minimal complications will favor segmental growth in the future. With various technological advances, saline-filled balloons segment will witness tremendous growth.

Hospitals segment is expected to expand at CAGR of 17.5% during the projected timeframe. Increased preference towards hospitals, availability of skilled professionals and high funding opportunities will accelerate industry growth. Segmental growth is attributable to increase in number of patient pool seeking advanced treatment options in hospitals, thereby favoring segmental growth over forecast timeframe.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/1173

UK intragastric balloon market will grow at 21.9% during the forecast period, owing to high pervasiveness of obesity. According to the Organization for Economic Co-operation and Development (OECD), more than one in four adults are diagnosed with obesity annually. Adoption of sedentary lifestyle and unhealth habits are major cause of high prevalence rate. High disposable income and increasing government expenditure on healthcare will further lead to business growth in the future.

China intragastric balloon market accounted for revenue size of USD 0.33 million in 2018 owing to rapid increase in the prevalence of obesity. As per a national population survey in Hong Kong, approximately 29% of the total population was found to be overweight and 3.8% population was obese. High pervasiveness is due to increasing adoption of sedentary lifestyle and unhealthy diet patterns, thereby propelling industry growth.

Some of the prominent players involved in intragastric balloon market are Allurion Technologies, Districlass Medical, Apollo Endosurgery, Lexel, Helioscopie Medical Implants, Medsil, Obalon Therapeutics, ReShape Medical, Silimed and Spatz. These firms adopt strategic initiatives including mergers and acquisitions, new product launch and geographical expansion. For instance, in December 2015, Allurion Technologies received CE mark for its Elipse Gastric Balloon. The approval permits the company to sell the product in the European Union, thereby expanding its customer base and strengthening the market position.

Report Content
Chapter 1. Methodology
1.1. Methodology
1.2. Market definitions
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary
Chapter 2. Executive Summary
2.1. Intragastric Balloon market industry 3600 synopsis, 2014 - 2025
2.1.1. Business trends
2.1.2. Product trends
2.1.3. Filling material trends
2.1.4. End-user trends
2.1.5. Regional trends
Chapter 3. Intragastric Balloon Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2014 - 2025
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Increasing global prevalence of obesity
3.3.1.2. Growing awareness among obese patients
3.3.1.3. Growing preference of patients towards non-surgical treatment for addressing obesity
3.3.1.4. Low price of intragastric balloon procedure
3.3.1.5. Rising demand for minimally invasive techniques
3.3.2. Industry pitfalls & challenges
3.3.2.1. Complications and risks related to intragastric balloon procedure
3.3.2.2. Lack of reimbursement
3.4. Growth potential analysis
3.4.1. By product
3.4.2. By filling material
3.4.3. By end-user
3.5. Porter’s analysis
3.6. Regulatory landscape
3.7. Competitive landscape, 2017
3.7.1. Strategy dashboard
3.8. Pipeline analysis
3.9. PESTEL analysis

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Blog : http://news-researchers.com/

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

This release was published on openPR.